Cara Therapeutics Inc. sell StockNews.com
Start price
16.05.25
/
50%
€0.37
Target price
16.05.26
-
Performance (%)
-
End price
17.05.26
-
Summary
This prediction was cancelled by the user.Performance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Cara Therapeutics Inc. | - | - | - |
| iShares Core DAX® | -1.779% | 2.475% | 1.471% |
| iShares Nasdaq 100 | 1.522% | 3.290% | 33.721% |
| iShares Nikkei 225® | 1.083% | 7.039% | 59.258% |
| iShares S&P 500 | 0.929% | 3.254% | 24.730% |
Comments by StockNews_com for this prediction
In the thread Cara Therapeutics Inc. diskutieren
Cara Therapeutics, Inc. (NASDAQ: CARA) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for CARA provided by MarketBeat
In the thread Trading Cara Therapeutics Inc.
Die von StockNews_com gewählte maximale Laufzeit wurde überschritten
Stopped prediction by StockNews_com for Cara Therapeutics Inc.
Cara Therapeutics Inc.
Start price
Target price
Perf. (%)
€0.54
17.02.24
17.02.24
-
17.02.25
17.02.25
-25.51%
18.02.25
18.02.25
